Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Versus Standard-Dose Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicentre, Non-Inferiority, Double-Blind, Randomised, Controlled Trial

NCT07088757 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT07088757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07088757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Versus Standard-Dose Rectal Indomethacin to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicentre, Non-Inferiority, Double-Blind, Randomised, Controlled Trial
Lead sponsor
Changhai Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
September 15, 2025
Completion date
December 1, 2026
Enrollment
1,366 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp pancreatitis